litlas
ログインアカウント作成

Sandy Srinivas

1995–2025 年に発表

95
論文数
21,007
被引用数
58
h 指数
90
i10 指数

被引用数

Sandy Srinivas の年別被引用数1997 年: 被引用 4 件1998 年: 被引用 3 件1999 年: 被引用 3 件2000 年: 被引用 1 件2001 年: 被引用 5 件2002 年: 被引用 3 件2003 年: 被引用 5 件2004 年: 被引用 8 件2005 年: 被引用 8 件2006 年: 被引用 8 件2007 年: 被引用 6 件2008 年: 被引用 19 件2009 年: 被引用 18 件2010 年: 被引用 23 件2011 年: 被引用 32 件2012 年: 被引用 48 件2013 年: 被引用 63 件2014 年: 被引用 96 件2015 年: 被引用 95 件2016 年: 被引用 137 件2017 年: 被引用 285 件2018 年: 被引用 326 件2019 年: 被引用 885 件2020 年: 被引用 1,000 件2021 年: 被引用 936 件2022 年: 被引用 611 件2023 年: 被引用 558 件2024 年: 被引用 1,048 件2025 年: 被引用 475 件2026 年: 被引用 16 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,714 件、この内訳の 25%中国: 引用元論文 1,126 件、この内訳の 10.4%イタリア: 引用元論文 668 件、この内訳の 6.1%イギリス: 引用元論文 628 件、この内訳の 5.8%ドイツ: 引用元論文 544 件、この内訳の 5%フランス: 引用元論文 517 件、この内訳の 4.8%カナダ: 引用元論文 486 件、この内訳の 4.5%スペイン: 引用元論文 381 件、この内訳の 3.5%日本: 引用元論文 344 件、この内訳の 3.2%オランダ: 引用元論文 310 件、この内訳の 2.8%オーストラリア: 引用元論文 296 件、この内訳の 2.7%スイス: 引用元論文 261 件、この内訳の 2.4%
0%25%その他 23.8%

機関

分野

  • Medicine83.9%
  • Biochemistry, Genetics and Molecular Biology9.4%
  • Immunology and Microbiology3.1%
  • Engineering0.9%
  • Computer Science0.7%
  • Economics, Econometrics and Finance0.2%
  • その他1.8%

トピック

  • Cancer Immunotherapy and Biomarkers11.2%
  • Prostate Cancer Treatment and Research7.3%
  • Bladder and Urothelial Cancer Treatments7.1%
  • Prostate Cancer Diagnosis and Treatment5.8%
  • Renal cell carcinoma treatment4.7%
  • Ferroptosis and cancer prognosis2.8%
  • その他61.1%

共著者

全論文

検索で開く
  1. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial

    著者: Jonathan E. Rosenberg, Jean Hoffman‐Censits, Tom Powles, Michiel S. van der Heijden, Arjun Vasant Balar, Andrea Necchi, Nancy A. Dawson, Peter H. O’Donnell, Ani Sarkis Balmanoukian, Yohann Loriot, Sandy Srinivas, Margitta Retz, Petros Grivas, Richard W. Joseph, Matthew D. Galsky, Mark T. Fleming, Daniel P. Petrylak, José Luis Perez‐Gracia, Howard A. Burris, Daniel Castellano, Christina Canil, Joaquim Bellmunt, Dean F. Bajorin, Dorothee Nickles, Richard Bourgon, Garrett M. Frampton, Na Cui, Sanjeev Mariathasan, Oyewale O. Abidoye, Gregg Fine, Robert Dreicer - The Lancet 2016 被引用: 3,714

  2. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

    著者: Arjun Vasant Balar, Matthew D. Galsky, Jonathan E. Rosenberg, Thomas Powles, Daniel P. Petrylak, Joaquim Bellmunt, Yohann Loriot, Andrea Necchi, Jean Hoffman‐Censits, José Luis Perez‐Gracia, Nancy A. Dawson, Michiel S. van der Heijden, Robert Dreicer, Sandy Srinivas, Margitta Retz, Richard W. Joseph, Alexandra Drakaki, Ulka N. Vaishampayan, Srikala S. Sridhar, David I. Quinn, Ignacio Durán, David R. Shaffer, Bernhard J. Eigl, Petros Grivas, Evan Y. Yu, Shi Li, Edward E. Kadel, Zachary Boyd, Richard Bourgon, Priti S. Hegde, Sanjeev Mariathasan, AnnChristine Thåström, Oyewale O. Abidoye, Gregg Fine, Dean F. Bajorin - The Lancet 2016 被引用: 2,211

  3. Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology

    著者: Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel A. Barocas, Rhonda L. Bitting, Alan H. Bryce, Brian F. Chapin, Heather H. Cheng, Anthony V. D’Amico, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, Michael Kuettel, Joshua M. Lang, Tamara L. Lotan, Rana R. McKay, Todd M. Morgan, George J. Netto, Julio M. Pow‐Sang, Robert E. Reiter, Mack Roach, Tyler P. Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Dorothy A. Shead, Jenna Snedeker, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2023 被引用: 571

  4. Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer

    著者: Christopher Hoimes, Thomas W. Flaig, Matthew I. Milowsky, Terence W. Friedlander, Mehmet Asım Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R. Merchan, Rana R. McKay, Daniel P. Petrylak, Carolyn Sasse, Blanca Homet Moreno, Yao Yu, Anne‐Sophie Carret, Jonathan E. Rosenberg - Journal of Clinical Oncology 2022 被引用: 267

  5. EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinoma

    著者: Jonathan E. Rosenberg, Srikala S. Sridhar, Jingsong Zhang, David C. Smith, Dean Ruether, Thomas W. Flaig, Joaquina Baranda, Joshua M. Lang, Elizabeth R. Plimack, Randeep Sangha, Elisabeth I. Heath, Jamie Merchan, David I. Quinn, Sandy Srinivas, Matthew I. Milowsky, Chunzhang Wu, Elaina M. Gartner, Peiying Zuo, Amal Melhem‐Bertrandt, Daniel P. Petrylak - Journal of Clinical Oncology 2020 被引用: 327

  6. Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer

    著者: Peter H. O’Donnell, Matthew I. Milowsky, Daniel P. Petrylak, Christopher Hoimes, Thomas W. Flaig, Nataliya Mar, Helen Moon, Terence W. Friedlander, Rana R. McKay, Mehmet Asım Bilen, Sandy Srinivas, Earle F. Burgess, Chethan Ramamurthy, Saby George, Daniel M. Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, J.P. Maroto Rey, Christiano Ferrario, Anne‐Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E. Rosenberg - Journal of Clinical Oncology 2023 被引用: 175

  7. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor–Induced Myocarditis

    著者: Han Zhu, Francisco X. Galdos, Daniel Lee, Sarah Waliany, Yuhsin Vivian Huang, Julia Ryan, Katherine Dang, Joel W. Neal, Heather A. Wakelee, Sunil Reddy, Sandy Srinivas, Lih‐Ling Lin, Ronald Witteles, Holden T. Maecker, Mark M. Davis, Patricia K. Nguyen, Sean M. Wu - Circulation 2022 被引用: 174

  8. NCCN Guidelines Insights: Prostate Cancer, Version 1.2021

    著者: Edward M. Schaeffer, Sandy Srinivas, Emmanuel S. Antonarakis, Andrew J. Armstrong, Justin E. Bekelman, Heather H. Cheng, Anthony V. D’Amico, Brian J. Davis, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Eric M. Horwitz, Joseph E. Ippolito, Michael Kuettel, Joshua M. Lang, Rana R. McKay, Jesse K. McKenney, George J. Netto, David F. Penson, Julio M. Pow‐Sang, Robert E. Reiter, Sylvia Richey, Mack Roach, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2021 被引用: 530

  9. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  10. Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong, Anthony V. D’Amico, Brian J. Davis, Tanya B. Dorff, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Joseph E. Ippolito, Christopher J. Kane, Michael Kuettel, Joshua M. Lang, Jesse K. McKenney, George J. Netto, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, Thomas J. Pugh, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ahmad Shabsigh, Eric J. Small, Daniel E. Spratt, Sandy Srinivas, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2019 被引用: 1,573

  11. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Thomas Powles, Piotr Tomczak, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Stefan N. Symeonides, Jaroslav Hájek, Howard Gurney, Yen‐Hwa Chang, Jae‐Lyun Lee, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Mauricio Mahave, Naomi B. Haas, Piotr Sawrycki, Joseph E. Burgents, Lei Xu, Kentaro Imai, David I. Quinn, Toni K. Choueiri, Piotr Tomczak, Toni K. Choueiri, Se Hoon Park, Balaji Venugopal, Thomas Ferguson, Jaroslav Hájek, Tzu-Ping Lin, Stefan N. Symeonides, Jae‐Lyun Lee, Piotr Sawrycki, Naomi B. Haas, Howard Gurney, Mauricio Mahave, Naveed Sarwar, Antoine Thiery-Vuillemin, Marine Gross‐Goupil, Christine Chevreau, John M. Burke, Gurjyot K. Doshi, Bohuslav Melichar, Delphine Topart, Stéphane Oudard, Evgeniy Kopyltsov, H. Hammers, David I. Quinn, Ajjai Alva, Juliana de Menezes, Adriano Gonçalves e Silva, Eric Winquist, Alketa Hamzaj, Giuseppe Procopio, Boguslawa Karaszewska, Ewa M. Nowakowska-Zajdel, B. Yа. Alekseev, Rustem Gafanov, А. А. Измайлов, Andrey Semenov, S. G. Afanasyev, Oleg Lipatov, T.B. Powles, Sandy Srinivas, David F. McDermott, Samith T. Kochuparambil, Ian D. Davis, Katriina Peltola, Roberto Sabbatini, Jinsoo Chung, М. I. Shkolnik, В. Б. Матвеев, P. Gajate Borau, Steven McCune, Thomas E. Hutson, Alejandro Dri, Silvio Correia Sales, Carrie Yeung, Carmen Marcela Alcala Castro, Peter J. Boström, Brigitte Laguerre, Consuelo Buttigliero, Ugo De Giorgi, Eugeniy A. Fomin, Yousef Zakharia, Clara Hwang, Eric A. Singer, Jeffrey T. Yorio, David Waterhouse, Rubén Dario Kowalyszyn, Margarita Sonia Alfie, Eduardo Yañez Ruiz, Tomáš Büchler, Krista Kankaanranta, G. Ferretti, Go Kimura, Kazuo Nishimura, Naoya Masumori, Satoshi Tamada, Haruaki Kato, Hiroshi Kitamura, Iwona Danielewicz ほか 133 名 - The Lancet Oncology 2022 被引用: 278

  12. Prostate Cancer, Version 3.2024

    著者: Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Rhonda L. Bitting, Brian F. Chapin, Heather H. Cheng, Anthony V. D’Amico, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xīn Gào, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, R. Jeffrey Karnes, Michael Kuettel, Joshua M. Lang, Tamara L. Lotan, Rana R. McKay, Todd M. Morgan, Julio M. Pow‐Sang, Robert E. Reiter, Mack Roach, Tyler P. Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Russell Z. Szmulewitz, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Jenna Snedeker, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2024 被引用: 272

  13. NCCN Guidelines® Insights: Prostate Cancer, Version 1.2023.

    著者: Edward M. Schaeffer, Sandy Srinivas, Nabil Adra, Yi An, Daniel A. Barocas, Rhonda L. Bitting, Alan H. Bryce, Brian F. Chapin, Heather H. Cheng, Anthony V. D’Amico, Neil Desai, Tanya B. Dorff, James A. Eastham, Thomas A. Farrington, Xin Gao, Shilpa Gupta, Thomas Guzzo, Joseph E. Ippolito, Michael Kuettel, Joshua M. Lang, Tamara L. Lotan, Rana R. McKay, Todd M. Morgan, George J. Netto, Julio M. Pow‐Sang, Robert E. Reiter, Mack Roach, Tyler P. Robin, Stan Rosenfeld, Ahmad Shabsigh, Daniel E. Spratt, Benjamin A. Teply, Jonathan D. Tward, Richard K. Valicenti, J.K. Wong, Ryan A. Berardi, Dorothy A. Shead, Deborah A. Freedman-Cass - 2022 被引用: 172

  14. Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

    著者: Thomas Powles, Peter H. O’Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher Hoimes, Jae‐Lyun Lee, Michael Ong, Srikala S. Sridhar, Nicholas J. Vogelzang, Mayer Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok Gupta, Yong Ben, Noah M. Hahn - JAMA Oncology 2017 被引用: 846

  15. Myocarditis Surveillance With High-Sensitivity Troponin I During Cancer Treatment With Immune Checkpoint Inhibitors

    著者: Sarah Waliany, Joel W. Neal, Sunil Reddy, Heather A. Wakelee, Sumit Shah, Sandy Srinivas, Sukhmani K. Padda, Alice C. Fan, A. Dimitrios Colevas, Sean M. Wu, Ronald Witteles, Han Zhu - JACC CardioOncology 2021 被引用: 118

  16. Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    著者: Silke Gillessen, Alberto Bossi, Ian D. Davis, Johann S. de Bono, Karim Fizazi, Nicholas D. James, Nicolas Mottet, Neal D. Shore, Eric J. Small, Matthew R. Smith, Christopher J. Sweeney, Bertrand Tombal, Emmanuel S. Antonarakis, Ana M. Aparicio, Andrew J. Armstrong, Gerhardt Attard, Tomasz M. Beer, Himisha Beltran, Anders Bjartell, Pierre Blanchard, Alberto Briganti, Robert G. Bristow, Muhammad Bulbul, Orazio Caffo, Daniel Castellano, Elena Castro, Heather H. Cheng, Kim N., Simon Chowdhury, Caroline S. Clarke, Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Rosalind A. Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Daniel J. George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia S. Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raya Leibowitz‐Amit, Christopher J. Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Alicia K. Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver A. Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Urology 2022 被引用: 118

  17. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

    著者: Andrea B. Apolo, Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh, Min Yuen Teo, Randy F. Sweis, Daniel M. Geynisman, Petros Grivas, Gurkamal Chatta, Zachery R. Reichert, Joseph W. Kim, Mehmet Asım Bilen, Bradley A. McGregor, Parminder Singh, Abhishek Tripathi, Suzanne Cole, Nicholas I. Simon, Scot A. Niglio, Lisa Ley, Lisa M. Cordes, Sandy Srinivas, Jiaoti Huang, Meagan Odegaard, Colleen Watt, Daniel P. Petrylak, Jeannie Hoffman-Censits, Yujia Wen, Olwen Hahn, Cecilia Mitchell, Alan W.C. Tan, Howard Streicher, Elad Sharon, Helen Moon, Michael Woods, Susan Halabi, Gabriela Perez Burbano, Michael J. Morris, Jonathan E. Rosenberg - New England Journal of Medicine 2024 被引用: 145

  18. Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study

    著者: Sumanta K. Pal, Bradley McGregor, Cristina Suárez, Che-Kai Tsao, William Kelly, Ulka Vaishampayan, Lance Pagliaro, Benjamin L. Maughan, Yohann Loriot, Daniel Castellano, Sandy Srinivas, Rana R. McKay, Robert Dreicer, Thomas Hutson, Sarita Dubey, Scott Werneke, Ashok Panneerselvam, Dominic Curran, Christian Scheffold, Toni K. Choueiri, Neeraj Agarwal - Journal of Clinical Oncology 2021 被引用: 140

  19. Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging

    著者: Hossein Jadvar, Jérémie Calais, Stefano Fanti, Felix Y. Feng, Kirsten L. Greene, James L. Gulley, Michael S. Hofman, Bridget F. Koontz, Daniel W. Lin, Michael J. Morris, Steve P. Rowe, Trevor J. Royce, Simpa S. Salami, Bital Savir-Baruch, Sandy Srinivas, Thomas A. Hope - Journal of Nuclear Medicine 2021 被引用: 143

  20. Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021)

    著者: Neeraj Agarwal, Bradley A. McGregor, Benjamin L. Maughan, Tanya B. Dorff, William Kevin Kelly, Bruno Fang, Rana R. McKay, Parminder Singh, Lance C. Pagliaro, Robert Dreicer, Sandy Srinivas, Yohann Loriot, Ulka N. Vaishampayan, Sanjay Goel, Dominic Curran, Ashok Panneerselvam, Martin Schwickart, Toni K. Choueiri, Sumanta K. Pal - The Lancet Oncology 2022 被引用: 66

  21. Phase II and Biomarker Study of the Dual MET/VEGFR2 Inhibitor Foretinib in Patients With Papillary Renal Cell Carcinoma

    著者: Toni K. Choueiri, Ulka N. Vaishampayan, Jonathan E. Rosenberg, Theodore F. Logan, Andrea Harzstark, Ronald M. Bukowski, Brian I. Rini, Sandy Srinivas, Mark N. Stein, Laurel M. Adams, Lone H. Ottesen, Kevin Laubscher, Laurie Sherman, David F. McDermott, Naomi B. Haas, Keith T. Flaherty, Robert W. Ross, Peter D. Eisenberg, Paul S. Meltzer, Maria J. Merino, Donald P. Bottaro, W. Marston Linehan, Ramaprasad Srinivasan - Journal of Clinical Oncology 2012 被引用: 458

  22. Prostate Cancer, Version 1.2016

    著者: James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony V. D’Amico, Brian J. Davis, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael E. Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow‐Sang, David Raben, Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward M. Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan D. Tward, Dorothy A. Shead, Deborah A. Freedman-Cass - Journal of the National Comprehensive Cancer Network 2016 被引用: 655

  23. PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

    著者: Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, H.P. Bagshaw, Mark K. Buyyounouski, Steven Hancock, Sumit Shah, Sandy Srinivas, Patrick S. Swift, Farshad Moradi, Guido Davidzon, Andrei Iagaru - Journal of Nuclear Medicine 2021 被引用: 66

  24. Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

    著者: Sumanta K. Pal, Guru Sonpavde, Neeraj Agarwal, Nicholas J. Vogelzang, Sandy Srinivas, Naomi B. Haas, Sabina Signoretti, Bradley A. McGregor, Jeremy O. Jones, Richard B. Lanman, Kimberly C. Banks, Toni K. Choueiri - European Urology 2017 被引用: 142